MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of vandetanib.
Ontology highlight
ABSTRACT: In this study, we performed microRNA (miRNA) expression profiling on a large series of sporadic and hereditary forms of medullary thyroid carcinomas (MTC). More than 60 miRNAs were significantly deregulated in tumor vs adjacent non-tumor tissues, partially overlapping with results of previous studies. We focused our attention on the strongest up-regulated miRNA in MTC samples, miR-375, the deregulation of which has been previously observed in a variety of human malignancies including MTC. We identified miR-375 targets by combining gene expression signatures from human MTC (TT) and normal follicular (Nthy-ori 3-1) cell lines transfected with an antagomiR-375 inhibitor or a miR-375 mimic, respectively, and from an in silico analysis of thyroid cell lines of Cancer Cell Line Encyclopedia data
SUBMITTER: Lassalle S
PROVIDER: S-EPMC5058693 | biostudies-literature | 2016 May
REPOSITORIES: biostudies-literature
ACCESS DATA